<code id='46FB6D975A'></code><style id='46FB6D975A'></style>
    • <acronym id='46FB6D975A'></acronym>
      <center id='46FB6D975A'><center id='46FB6D975A'><tfoot id='46FB6D975A'></tfoot></center><abbr id='46FB6D975A'><dir id='46FB6D975A'><tfoot id='46FB6D975A'></tfoot><noframes id='46FB6D975A'>

    • <optgroup id='46FB6D975A'><strike id='46FB6D975A'><sup id='46FB6D975A'></sup></strike><code id='46FB6D975A'></code></optgroup>
        1. <b id='46FB6D975A'><label id='46FB6D975A'><select id='46FB6D975A'><dt id='46FB6D975A'><span id='46FB6D975A'></span></dt></select></label></b><u id='46FB6D975A'></u>
          <i id='46FB6D975A'><strike id='46FB6D975A'><tt id='46FB6D975A'><pre id='46FB6D975A'></pre></tt></strike></i>

          fashion

          fashion

          author:explore    Page View:16
          Adobe

          Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

          The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl Icahn.

          advertisement

          During the battle, there had been speculation that Jay Flatley, deSouza’s predecessor, could return. Under Flatley, Illumina had grown from an upstart to the dominant player in a field that has proved pivotal for medical research and delivered sizable returns to investors.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more
          STAT Virtual Event: The State of Biosimilars: What to Watch
          STAT Virtual Event: The State of Biosimilars: What to Watch

          Editor’snote:Arecordingoftheeventisembeddedbelow.NowthatbiosimilarversionsofHumiraarestartingtoarriv

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Medicare to cover more brain scans for Alzheimer’s patients

          AnewlyapprovedAlzheimer’sdrugmadebyEisaiandBiogen,calledLeqembi,aimstoclearoutamyloidplaquesinpatien